Rijuven Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $2.28M
Latest Deal Amount

Rijuven General Information

Description

Developer of a healthcare technology platform designed to leverage ubiquitous mobile infrastructure. The company's platform offers medical and consumer health devices for comprehensive heart analysis for health examination, remote monitoring and management, enabling health institutions to treat patients effectively, saving time, cost and lives.

Contact Information

Website
www.rijuven.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 10475 Perry Highway
  • Suite 104
  • Wexford, PA 15090
  • United States
+1 (412) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rijuven Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 26-Jun-2017 $2.28M 00.000 Completed Generating Revenue
6. Early Stage VC 08-Jan-2015 00000 00.000 Completed Startup
5. Early Stage VC 13-Nov-2014 00000 00.000 Completed Startup
4. Early Stage VC 03-Apr-2014 00000 00.000 Completed Startup
3. Seed Round 17-Jul-2013 00000 00.000 Completed Startup
2. Seed Round 23-Aug-2012 $875K $2.17M Completed Startup
1. Angel (individual) 01-Jan-2012 $1.3M $1.3M Completed Startup
To view Rijuven’s complete valuation and funding history, request access »

Rijuven Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a healthcare technology platform designed to leverage ubiquitous mobile infrastructure. The company's platf
Diagnostic Equipment
Wexford, PA
7 As of 2020
00.000
0000000000 0 00.000

00000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000000000 000000000
Sunnyvale, CA
00 As of 0000
00.000
0000000000 00.000

000000

od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000000000 000000000
San Francisco, CA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rijuven Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardiomo Accelerator/Incubator Backed Sunnyvale, CA 00 00.000 0000000000 00.000
000000 Venture Capital-Backed San Francisco, CA 00 000.00 0000000000 0 000.00
00000000000000000 Venture Capital-Backed Wilmington, DE 00 00.000 00000000000 00.000
You’re viewing 3 of 3 competitors. Get the full list »

Rijuven Executive Team (7)

Name Title Board Seat Contact Info
Evens Augustin Co-Founder & Chief Executive Officer
Raj Kapoor MD Co-Founder, President & Board Member
Justin Bass Chief Strategist
Lucius Polk Chief Marketing Officer & Co-Founder
Taras Silecky Chief Business Development Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Rijuven Board Members (2)

Name Representing Role Since
Neil Niren Rijuven Co-Founder, Board Member & Member of the Medical and the Advisory board 000 0000
Raj Kapoor MD Rijuven Co-Founder, President & Board Member 000 0000
To view Rijuven’s complete board members history, request access »

Rijuven Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial